Navigation Links
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Date:1/28/2009

of $13.6 million.
  • Biomaterial product sales of $25.8 million, representing an increase of 19% from prior fiscal year period.
  • Orthopaedic royalties of $2.9 million, representing an increase of 33% from prior fiscal year period.
  • President and CEO Commentary

    "Our second quarter results demonstrated that our business fundamentals remain solid," said Joe Kaufmann, President and CEO of the Company. "For the second consecutive quarter, we have achieved record earnings and double digit increases in our biomaterial sales and orthopaedic royalties. Our balance sheet continued to strengthen by generating $4.7 million in operating cash flow in the quarter and $13.6 million through the first half of our fiscal year, and we currently expect our operating cash flow for the full fiscal year will be over $25 million. Our Angio-Seal royalties remained solid at $5.4 million despite the negative impact of foreign currency exchange of approximately $200,000. We have continued to make significant progress with both of our cartilage repair and extracellular matrix technology programs during the quarter and both programs remain on schedule. Additionally, our endovascular development programs have continued on schedule and we expect to achieve an additional milestone by the end of our fiscal year. Obviously, the current economic climate continues to be a concern and the deterioration of the Euro has adversely impacted our Angio-Seal royalties in the second quarter and our royalty expectations for the fiscal year."

    Second Quarter Results

    Revenues: Sales and Royalties. Total revenues increased 6% to $20.8 million in the Company's fiscal quarter ended December 31, 2008, from $19.6 million in the comparable prior fiscal year period.

    Net sales increased 6% to $14.0 million in the second quarter of fiscal 2009 from $13.1 million in the sec
    '/>"/>

    SOURCE Kensey Nash Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related biology technology :

    1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
    2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
    3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
    4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
    5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
    6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
    7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
    8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
    9. GEN Reports on Growing Reliance on Microfluidics Technology
    10. Novozymes Reports Strong 2008 Results
    11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)...   HX360 today announced that sixteen companies ... Innovation Challenge competition. These companies, selected from a ... as one of four finalists to present their solutions ... and venture capitalists during the Innovation Challenge event. ... the 2015 HIMSS Annual Conference & Exhibition, McCormick Place ...
    (Date:3/5/2015)... 2015 Bi-Biomics today announced a ... stain additive. The improvement in histological quality provided ... present in all daughter cells. , After processing ... was analyzed at 1000-1600x using light microscopy. ... in all daughter cells displayed predominant binary features ...
    (Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Mature Biotech Outlook 2015: New Therapy Ventures ... offering. All biotech companies - Gilead ... in past year, have given a positive return and ... have been able to select therapy/niche indication where the ...
    (Date:3/5/2015)... 2015 RMI specializes ... orthopedic conditions such as meniscal tears, ACL injuries, ... joint pain due to degenerative conditions like osteoarthritis. ... surgeries to promote better post-surgical outcomes. , Stemnexa ... pain-free bone marrow harvesting with two complimentary cellular ...
    Breaking Biology Technology:HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5
    ... Microscopic robots crafted to maneuver separately without any obvious ... of continuing research led by a Duke University computer ... assembly and control at this fine a resolution with ... Duke professor of computer science and biochemistry. , Each ...
    ... Pharmaceuticals,Inc. (Nasdaq: AMLN ) today announced that ... diabetes drugs, BYETTA(R) (exenatide) injection and,SYMLIN(R) (pramlintide acetate) ... at the American Diabetes Association,s 68th Annual,Scientific Sessions ... June 6 to,10. The company will also host ...
    ... June 2 , CALL DATE: Tuesday, June 3, 2008, ... Time, HOST: Dr. Candace ... conduct a telephone conference call and,simultaneous webcast on Tuesday, June 3 ... Research Corporation that,was announced on May 30 and to provide an ...
    Cached Biology Technology:Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2
    (Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
    (Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
    (Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
    Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2
    ... The first comprehensive study of the biological effects of Antarctic ... growth of algae that take up carbon dioxide from the ... the deep sea. This process is detailed in 19 new ... journal Deep Sea Research Part II: Topical Studies in ...
    ... of Energy (DOE) Office of Science Early Career Research ... Institute scientist Susannah Green Tringe to conduct genomic studies ... San Francisco Bay-Delta region of California. Tringe, ... other applicants had been awarded funding for their projects ...
    ... and kid goats recognise each other,s calls soon after the ... London reveals. The study, published in the journal ... and the ability of goats to recognise the individual differences. ... Queen Mary,s School of Biological and Chemical Sciences found that ...
    Cached Biology News:Antarctic icebergs help the ocean take up carbon dioxide 2Antarctic icebergs help the ocean take up carbon dioxide 3JGI's Susannah Tringe receives prestigious $2.5M DOE Early Career Research Award 2
    ...
    ... miRCURY LNA technology enables sensitive and specific ... miRCURY LNA Detection probes have high binding ... sensitive detection of miRNAs. Due to the ... probes less than 1/10 the amount of ...
    ... Roches RTS AviTag E. coli Biotinylation Kit, ... RTS 100 E. coli expression kits. (Cat. No. ... provides reagents to rapidly generate linear expression constructs ... expression based on a combination of T7 RNA ...
    ... Competitor Assay Kits are ideal for studying ... PolarScreen GR Competitor Assay Kits contain partially ... one of the following proprietary fluorescent glucocorticoid ... Red (red assay kit), or GS Far ...
    Biology Products: